LABORATORY NEWS
-
Eurobio Scientific Finalizes The Acquisition Of CareDX's Transplant Lab Product Division
Eurobio Scientific, a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, today announces that it has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitutes the Lab Products division of CareDx, Inc., a US global precision medicine company focused on transplantation.
- Tribun Health Announces CaloPix 6, Its First IVDR-Certified Version For Routine Diagnostic Use
- Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib DRP® Companion Diagnostic
- InterVenn Biosciences And Aranscia Expand Commercialization Partnership For GlycoKnow™ Ovarian Cancer Diagnostic Test
- Roche Announces The Launch Of AXELIOS 1, A Transformative Next-Generation Sequencing Platform
ARCHIVED NEWSLETTER
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?